Skip to content
November 16, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Surgery and Reconstruction
  • Advancing the Future of Reconstructive Science: Dr. Sara R. Dickie Named President of The Plastic Surgery Foundation
  • Breast Cancer Surgery and Reconstruction

Advancing the Future of Reconstructive Science: Dr. Sara R. Dickie Named President of The Plastic Surgery Foundation

Azzam Bilal Chamdy November 16, 2026 7 minutes read
advancing-the-future-of-reconstructive-science-dr-sara-r-dickie-named-president-of-the-plastic-surgery-foundation

HOUSTON – In a significant transition for one of the world’s most influential medical research bodies, Sara R. Dickie, MD, has been officially inaugurated as the President of The Plastic Surgery Foundation (The PSF). The announcement was made during Plastic Surgery The Meeting, the American Society of Plastic Surgeons’ (ASPS) premier annual scientific conference held in Houston, Texas.

As the philanthropic and research arm of the ASPS, The PSF plays a critical role in funding clinical studies, fostering innovation, and supporting international medical outreach. Dr. Dickie, a distinguished Chicago-based surgeon, is set to lead the organization through a pivotal three-year term, with her tenure concluding on September 19, 2027. Her appointment marks a strategic shift toward integrating private-practice innovation with large-scale academic research.

The Mandate: Strategic Direction and Innovation

Dr. Dickie’s presidency arrives at a time when the field of plastic and reconstructive surgery is undergoing a technological renaissance. From the integration of artificial intelligence in surgical planning to breakthroughs in regenerative medicine and tissue engineering, the mandate for The PSF has never been more expansive.

As President, Dr. Dickie will oversee the strategic direction of the foundation, focusing on three core pillars: bolstering research grants, fostering innovation in surgical techniques, and strengthening global partnerships to elevate patient outcomes.

"The PSF has a longstanding legacy of supporting the people and programs that shape the future of plastic surgery," Dr. Dickie stated in her inaugural address. "The most meaningful advances happen when researchers, surgeons, and advocates work together toward a common goal. I look forward to building on that foundation to strengthen opportunities for collaboration that ultimately benefit patients and the specialty."

Chronology: A Career Built on Leadership and Advocacy

Dr. Dickie’s path to the presidency of The PSF is characterized by a decade of dedicated service within the American Society of Plastic Surgeons. Since becoming an active member in 2015, she has systematically taken on roles that bridge the gap between clinical practice and organizational leadership.

Early Career and Academic Foundations

Before her rise to national leadership, Dr. Dickie cultivated a profound respect for the intersection of medicine and artistry. An alumna of the University of Chicago Pritzker School of Medicine, she was drawn to the specialty specifically because of its unique requirement for a synthesis of complex anatomical knowledge, technical innovation, and creative problem-solving. This academic background served as the bedrock for her eventual transition into private practice.

Transition to Leadership

Throughout her tenure with the ASPS, Dr. Dickie has demonstrated a keen aptitude for navigating the complex financial and structural challenges of a major medical society. Her roles have been diverse, spanning:

  • Public Education Initiatives: Focused on demystifying plastic surgery for the general public and advocating for patient safety.
  • Professional Development: Mentoring the next generation of plastic surgeons to ensure the specialty remains vibrant and evidence-based.
  • Philanthropic Strategy: Serving as the Board Vice President of Development, where she was instrumental in scaling fundraising efforts. These initiatives have been vital in financing the research grants that allow surgeons to pursue long-term clinical studies that would otherwise lack institutional backing.

Supporting Data: The Impact of The PSF

To understand the weight of Dr. Dickie’s new position, one must consider the scope of The PSF’s influence. The foundation acts as the primary engine for discovery in the specialty. According to data provided by the ASPS and The PSF, the organization has historically been the largest private funder of plastic surgery research in the United States.

Grant Allocation and Research Growth

The PSF provides critical seed funding for "pilot" studies—the preliminary data-gathering phases that often lead to larger National Institutes of Health (NIH) grants. By funding high-risk, high-reward research, the foundation has directly contributed to advancements in:

  • Lymphedema management: Improving quality of life for cancer survivors.
  • Complex wound care: Developing new protocols for trauma and burn victims.
  • Patient-Reported Outcome (PRO) tools: Standardizing how surgeons measure the success of a procedure from the patient’s perspective.

Under Dr. Dickie’s leadership, the foundation is expected to prioritize these "translational" studies—research that can be taken from the laboratory bench directly to the operating table.

Official Responses and Industry Sentiment

The appointment has been met with enthusiasm from within the medical community. Colleagues note that Dr. Dickie’s unique perspective as a solo private-practice surgeon provides her with a "boots-on-the-ground" understanding of the challenges faced by the majority of the ASPS membership.

"Dr. Dickie possesses that rare combination of clinical excellence and administrative vision," said a representative from the ASPS leadership council. "She understands that for the Foundation to remain relevant, it must support the surgeons who are in the community every day, not just those in ivory-tower research centers."

The emphasis on "community-based research" is expected to be a hallmark of her term. By empowering private practitioners to engage in clinical trials, the foundation hopes to collect a broader, more diverse set of data that reflects the realities of modern medical practice.

Implications for the Future of Plastic Surgery

Dr. Dickie’s term, spanning from 2024 to 2027, will likely be defined by the maturation of digital health and the ethics of new aesthetic and reconstructive technologies. As the founder and lead surgeon of Surgical Aesthetics + Reconstructive Arts in the Chicago area, Dr. Dickie operates at the intersection of these advancements.

Bridging the Gap: Aesthetics and Reconstruction

One of the core tensions in plastic surgery is the perceived divide between aesthetic (cosmetic) and reconstructive procedures. Dr. Dickie has consistently argued that these fields are not mutually exclusive, but rather complementary. Her leadership is expected to emphasize that the innovations found in cosmetic surgical techniques—such as minimally invasive approaches and rapid recovery protocols—can and should be applied to reconstructive surgery to improve patient recovery and satisfaction.

Global Collaboration

The PSF is not limited to domestic efforts. Dr. Dickie is slated to expand the foundation’s international footprint. By fostering relationships with surgical societies in Europe, Asia, and Latin America, she aims to create a global network of data sharing. This is particularly important for rare conditions or traumatic injuries where a single nation’s patient population might be too small to reach statistically significant conclusions.

The Financial Sustainability of Research

Perhaps the most significant challenge Dr. Dickie faces is the long-term sustainability of medical research funding. With healthcare economics becoming increasingly complex, the philanthropic model used by The PSF must evolve. Her experience as the former Board Vice President of Development will be tested as she navigates the need for increased endowments and corporate partnerships to ensure that the next generation of plastic surgeons has the resources they need to innovate.

A Vision for 2027

As Dr. Dickie steps into the role of President, the medical community looks toward 2027 with anticipation. Her leadership style—described by peers as collaborative, data-driven, and highly organized—suggests a tenure focused on steady, impactful growth.

By the time she concludes her term in September 2027, the goal is for The Plastic Surgery Foundation to be more integrated into the daily practice of the average surgeon. If successful, Dr. Dickie will leave behind a legacy where research is no longer an isolated pursuit, but a fundamental component of every plastic surgeon’s career.

In her own words, the mission is clear: "We are at a point where the art and the science of what we do are converging more rapidly than ever. My goal is to ensure that the surgeons who are doing this work have the tools, the funding, and the collaborative network to turn today’s innovative idea into tomorrow’s standard of care."

With her formal induction now complete, the countdown to 2027 begins. For the field of plastic surgery, the next three years promise to be a period of significant progress, guided by a leader who remains committed to the dual ideals of clinical excellence and scientific advancement.

About the Author

Azzam Bilal Chamdy

Author

View All Posts

Post navigation

Previous: Eli Lilly Continues Historic M&A Streak with $1.5 Billion Acquisition of Calytrix Bio

Related Stories

the-transparency-gap-why-patients-seeking-breast-reconstruction-remain-in-the-dark-regarding-costs
  • Breast Cancer Surgery and Reconstruction

The Transparency Gap: Why Patients Seeking Breast Reconstruction Remain in the Dark Regarding Costs

Pevita Pearce November 16, 2026
beyond-wrinkles-the-emerging-role-of-botulinum-toxin-in-advanced-scar-management
  • Breast Cancer Surgery and Reconstruction

Beyond Wrinkles: The Emerging Role of Botulinum Toxin in Advanced Scar Management

Suro Senen November 15, 2026
a-new-era-of-leadership-dr-lynn-a-damitz-takes-the-helm-of-the-american-society-of-plastic-surgeons
  • Breast Cancer Surgery and Reconstruction

A New Era of Leadership: Dr. Lynn A. Damitz Takes the Helm of the American Society of Plastic Surgeons

Basiran November 15, 2026

Recent Posts

  • Advancing the Future of Reconstructive Science: Dr. Sara R. Dickie Named President of The Plastic Surgery Foundation
  • Eli Lilly Continues Historic M&A Streak with $1.5 Billion Acquisition of Calytrix Bio
  • Bridging the Transparency Gap: How Rx Almanac is Disrupting Pharma’s "Word-of-Mouth" Vendor Culture
  • A Decade of Resilience: The Advocacy and Impact of Roxana Guerra
  • The Global Quest for Origins: WHO Initiates Scientific Mission to China to Unravel SARS-CoV-2 Roots

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

advancing-the-future-of-reconstructive-science-dr-sara-r-dickie-named-president-of-the-plastic-surgery-foundation
  • Breast Cancer Surgery and Reconstruction

Advancing the Future of Reconstructive Science: Dr. Sara R. Dickie Named President of The Plastic Surgery Foundation

Azzam Bilal Chamdy November 16, 2026
eli-lilly-continues-historic-ma-streak-with-1-5-billion-acquisition-of-calytrix-bio
  • Chemotherapy and Targeted Therapy

Eli Lilly Continues Historic M&A Streak with $1.5 Billion Acquisition of Calytrix Bio

Basiran November 16, 2026
bridging-the-transparency-gap-how-rx-almanac-is-disrupting-pharmas-word-of-mouth-vendor-culture
  • Chemotherapy and Targeted Therapy

Bridging the Transparency Gap: How Rx Almanac is Disrupting Pharma’s "Word-of-Mouth" Vendor Culture

Ammar Sabilarrohman November 16, 2026
a-decade-of-resilience-the-advocacy-and-impact-of-roxana-guerra
  • Metastatic Breast Cancer Research

A Decade of Resilience: The Advocacy and Impact of Roxana Guerra

Evan Lee Salim November 16, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.